Eager But Wary: Industry Seeks More Useful, More Detailed Remote Regulatory Assessment Processes
Executive Summary
Responses to US FDA draft guidance suggest more promptness while also more elaborate processes for agency decision making based on remote methods. Questions include what’s voluntary, what’s mandatory, what can be decided remotely, and how to remotely move on from warning letters.